Massimo Breccia, Andreas Hochhaus, Philipp le Coutre, Dragana Milojkovic, Dennis Kim, Soo Min Lim, Carolina Pavlovsky, Thanh Nguyen, Franck Nicolini, Elena Moiraghi, Sebastian Grosicki, Chi Dung Phu, Gabriel Etienne, Fernando Marco De Lucas, Rosa Ayala Diaz, Roberto Abi Rached, Soyoun Park, Peter Schuld, Virginia Pilipovic, Aswin IC, Franz Alisch, Carla Maria Boquimpani, Charles Chuah. "ASC4OPT 96-week results: Asciminib once or twice daily continues to be highly efficacious and demonstrates favorable safety in patients with chronic myeloid leukemia and suboptimal response, resistance or intolerance to two or more tyrosine kinase inhibitors." Blood, 2025. doi:10.1182/blood-2025-1993